title: The management of motor neurone disease.
authors.affiliation: The King's MND Care and Research Centre, Institute of Psychiatry, Guy's King's and St Thomas's School of Medicine, and King's College Hospital, London, UK. n.leigh@iop.kcl.ac.uk
authors.forename: P N
authors.initials: PN
authors.lastname: Leigh
authors.forename: S
authors.initials: S
authors.lastname: Abrahams
authors.forename: A
authors.initials: A
authors.lastname: Al-Chalabi
authors.forename: M-A
authors.initials: MA
authors.lastname: Ampong
authors.forename: L H
authors.initials: LH
authors.lastname: Goldstein
authors.forename: J
authors.initials: J
authors.lastname: Johnson
authors.forename: R
authors.initials: R
authors.lastname: Lyall
authors.forename: J
authors.initials: J
authors.lastname: Moxham
authors.forename: N
authors.initials: N
authors.lastname: Mustfa
authors.forename: A
authors.initials: A
authors.lastname: Rio
authors.forename: C
authors.initials: C
authors.lastname: Shaw
authors.forename: E
authors.initials: E
authors.lastname: Willey
mesh_terms: D005774:Gastrostomy; D005817:Genetic Counseling; D006801:Humans; D016472:Motor Neuron Disease / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D012121:Respiration, Artificial; D019782:Riluzole / Q000627:therapeutic use; D013727:Terminal Care
chemical_list: D018696:Neuroprotective Agents; D019782:Riluzole